DNA Compass

DNA Compass is a private, pre-revenue platform company founded in 2018 that has developed a novel approach to genomic data interoperability. By treating genomic coordinates as location data, the company utilizes established mapping software (ESRI) to build a secure, federated network for data sharing, aiming to accelerate research and clinical trial matching. Its business model centers on providing technology and services to patient advocacy groups, researchers, and pharmaceutical companies, facilitating collaboration while prioritizing patient control over data. The company is at an early stage, building its technology platform and ecosystem partnerships.

A federated genomic data management and exchange platform that repurposes ESRI-based geospatial mapping software to treat genomic coordinates as location data, enabling secure, patient-centric data sharing with open APIs and adherence to FHIR, GA4GH, and HL7 standards.

DNA Compass competes in the genomic data ecosystem with centralized cloud platforms (e.g., DNAnexus, Google Genomics), EHR-linked research networks, and other interoperability solution providers. Its key differentiation is the federated model using mapping software, emphasizing local data control and patient sovereignty, which may appeal to entities wary of centralizing sensitive data.